Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

Putting Patients First grant, 2015 winners, AHRA, Toshiba

News | Radiology Imaging | January 28, 2016

AHRA and Toshiba Announce 2015 Putting Patients First Grant Winners

January 28, 2016 — Seven leading healthcare providers have been selected as recipients of the eighth annual Putting...

UltraSPECT, 450th U.S. installation, Firelands Regional Medical Center, nuclear medicine, radiation safety

News | Nuclear Imaging | January 27, 2016

UltraSPECT Marks 450th U.S. System Installation

January 27, 2016 — UltraSPECT Inc. has marked the 450th U.S. installation of its low-dose image processing technology...

News | Radiopharmaceuticals and Tracers | January 26, 2016

Nuclear Medicine Tools Could Be Beneficial Against Several Cancers

January 26, 2016 — University of Missouri researcher Silvia Jurisson and her interdisciplinary team recently received a...

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Staging F18FDG PET/CT images of adenocarcinoma in the RUL (right upper lobe) of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. (Images courtesy of Dr. Jay Kikut and UVMC)

Blog | PET-CT | October 25, 2018

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both.

prostate cancer, imaging agent, 64Cu-TP3805, PET/CT, Thomas Jefferson University study

News | Radiopharmaceuticals and Tracers | January 21, 2016

Imaging Test Accurately Detects Extent of Prostate Cancer in Patients

January 21, 2016 — Researchers at Thomas Jefferson University have found the method they developed to image the...

Siemens, Biograph Horizon PET CT, FDA clearance

Technology | PET-CT | January 21, 2016

Siemens Receives FDA Clearance for Biograph Horizon PET/CT System

January 21, 2016 — Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...

Gamma Medica, LumaGEM, molecular breast imaging, Kingdom of Saudi Arabia, KSA approval

News | Breast Imaging | January 18, 2016

Saudi Food and Drug Authority Approves LumaGEM Molecular Breast Imaging Solution

January 18, 2016 — Gamma Medica Inc. announced the Saudi Food and Drug Authority (SFDA) has issued a Medical Device...

Gamma Medica, Alpha Imaging, LumaGEM molecular breast imaging system, MBI, distribution agreement

News | Breast Imaging | January 08, 2016

Alpha Imaging to Distribute Gamma Medica’s Molecular Breast Imaging System

January 8, 2016 — Alpha Imaging, an independent sales and service provider of advanced medical imaging equipment,...

Jeffrey W. Prescott, M.D., Ph.D.

News | Clinical Trials | December 30, 2015

RSNA Presents Alexander Margulis Award to Alzheimer’s Study

The Radiological Society of North America (RSNA) presented its fourth...

News | Radiology Imaging | December 28, 2015 | Dave Fornell

Toshiba May Sell its Healthcare Division as Part of its Financial Reforms

December 28, 2015 — Toshiba announced Dec. 21 it is considering selling off its healthcare division as part of its...

News | Prostate Cancer | December 18, 2015

Cancer Targeted Technology Receives $2.3 Million Small Business Fast-Track Contract to Develop an Innovative PSMA-Targeted Radionuclide Therapy for Prostate Cancer

Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and...

Lymphoseek, RSNA 2015, clinical study, sentinel lymph node mapping, SLN

Image courtesy of Navidea Biopharmaceuticals

News | Oncology Diagnostics | December 11, 2015

Study Shows Lymphoseek Reduces Sentinel Lymph Node Biopsy Imaging Time

December 11, 2015 — Navidea Biopharmaceuticals Inc. announced that results from an investigator-initiated imaging study...

Dilon Diagnostics, GE Healthcare, distribution, Discovery NM750b Molecular Breast Imaging System, RSNA 2015

Technology | Molecular Imaging | December 10, 2015

Dilon Diagnostics to Distribute GE’s Discovery NM750b Molecular Breast Imaging System

December 10, 2015 — Dilon Diagnostics and GE Healthcare announced the signing of an agreement for Dilon to distribute...

Siemens’ 510(k) pending MRI application Simultaneous Multi-Slice (SMS)¹ is based on an acceleration technology that speeds up 2-D acquisition time by a factor of three, enabling advanced MRI applications such as DTI (diffusion tensor imaging) and BOLD (blood oxygen level dependent) in the clinical routine.

Technology | Magnetic Resonance Imaging (MRI) | November 29, 2015

Siemens Debuts New Brain MR Efficiency Applications

November 29, 2015 — At the 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America (...

News | SPECT-CT | November 24, 2015

Revolutionary Whole-body CZT Digital SPECT/CT

Molecular Dynamics will present its revolutionary whole body CZT digital SPECT/CT solution at RSNA 2015. The company...